RxSight to Participate in the Ophthalmology Day at BTIG

ALISO VIEJO, Calif., Nov. 18, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced plans to participate in the upcoming virtual Ophthalmology Day at BTIG.

RxSight’s management is scheduled to participate in a fireside chat Tuesday, November 30, 2021, at 8:30am PT / 11:30am ET. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at: https://investors.rxsight.com/.

About RxSight, Inc.
RxSight, Inc. is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. The RxSight Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens (LAL®), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The LAL now features ActivShield™ technology, a revolutionary UV protection layer built into the lens. Additional information about RxSight can be found at www.rxsight.com.

Investor Relations Contact:
Philip Taylor
Gilmartin Group
415.937.5406
[email protected] 

You May Also Be Interested In

• She Made it – the Youngest South African Woman to Swim the Channel
• Alibaba Group Announced Pricing of HK$80 Billion Placing of New Shares in Hong Kong
• Why Visual Asset Repurposing Is Becoming a Competitive Advantage